Fortress Biotech Inc.

NASDAQ: FBIO · Real-Time Price · USD
1.97
0.01 (0.51%)
At close: Aug 14, 2025, 3:59 PM

Fortress Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
57.67M 84.51M 75.74M 68.79M
Cost of Revenue
20.88M 22.89M 30.77M 32.08M
Gross Profit
36.8M 61.62M 44.97M 36.71M
Operating Income
-110.38M -142.34M -203.56M -188.54M
Interest Income
2.68M 3M 1.4M 649K
Pretax Income
-120.54M -153.63M -213.46M -164.35M
Net Income
-46M -60.64M -86.58M -64.7M
Selling & General & Admin
87.73M 90.98M 113.66M 86.84M
Research & Development
56.88M 106.07M 134.88M 128.87M
Other Expenses
2.56M 6.91M -1.3M 9.54M
Operating Expenses
147.18M 203.96M 247.23M 225.25M
Interest Expense
9.93M 12.52M 13.64M 15.31M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
168.05M 226.85M 278M 247.79M
Income Tax Expense
312K 521K 449K 473K
Shares Outstanding (Basic)
20.78M 8.11M 5.92M 5.45M
Shares Outstanding (Diluted)
20.78M 8.11M 5.92M 5.45M
EPS (Basic)
-2.69 -8.47 -14.55 -11.85
EPS (Diluted)
-2.69 -8.47 -14.55 -11.85
EBITDA
-104.49M -135.72M -190.47M -146.17M
EBIT
-108.95M -141.72M -203.05M -149.04M
Depreciation & Amortization
4.46M 6M 9.35M 6.79M